
Incidents of early-onset bowel cancer have doubled in numerous countries over the past two decades, prompting investigation into the underlying causes. While established risk factors such as obesity, smoking, and alcohol consumption are known contributors, researchers have determined these factors can account for only approximately half of diagnosed cases, suggesting additional mechanisms are at play.
Scientists have identified colibactin, a toxin produced by certain E. coli variants residing in the gastrointestinal tract, as a potential primary factor in the rise of early-onset colorectal cancer. Research from the previous year revealed that mutations characteristic of colibactin exposure appeared three times more frequently in tumors from individuals under 40 compared to those over 70. Dr. Karl Smith-Byrne of the University of Oxford characterized colibactin as “probably the leading explanation at the moment” for the phenomenon when addressing lawmakers.
Research suggests colibactin-producing bacteria may induce mutations during early childhood or infancy, potentially establishing a foundation for cancer development decades later. Some researchers theorize that specific E. coli variants may have evolved in recent decades to produce the toxin, with evidence indicating colibactin is predominantly found in individuals born after 1960. These early-life exposures could occur during childhood or even prenatally, complicating epidemiological investigation.
While colibactin represents a significant new avenue of inquiry, investigators emphasize that more research is necessary to establish causation. Concurrently, public health experts note that known preventable risk factors remain important, with potential to address approximately 60% of current cases. Bowel cancer ranks as the third most common cancer globally, accounting for roughly one in ten cases overall, though it remains far more prevalent in populations over 50.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI